Details of the Drug Reposition

General Information of This Drug (ID: DMW7UL0)

Drug Name
Ixmyelocel-T   DMW7UL0
Synonyms
Bone marrow-derived stem cell therapy, Aastrom; Bone marrow-derived stem cell therapy (limb ischemia), Aastrom; Bone marrow-derived CRCs (cardiac regeneration/dilated cardiomyopathy), Aastrom; Bone marrow-derived cardiac repair cells (cardiac regeneration/dilated cardiomyopathy), Aastrom; Bone marrow-derived stem cell therapy (cardiac regeneration/dilated cardiomyopathy), Aastrom; Bone marrow-derived TRC's (cardiac regeneration/dilated cardiomyopathy), Aastrom; Bone marrow-derived tissue repair cells, (cardiac regeneration/dilated cardiomyopathy), Aastrom

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
2 Phase 3 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Type-1 diabetes DIS7HLUB 5A10 Phase 3 [1]
Dilated cardiomyopathy DISX608J BC43.0 Phase 3 [2]
------------------------------------------------------------------------------------
1 Phase 2 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Heart failure DISJW62S BD10-BD13 Phase 2 [3]
------------------------------------------------------------------------------------

References

1 ClinicalTrials.gov (NCT01483898) An Efficacy and Safety Study of Ixmyelocel-T in Patients With Critical Limb Ischemia (CLI). U.S. National Institutes of Health.
2 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
3 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)